<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1448210&amp;fmt=gif">

Transformational Technology Summit: the End-To-End Vaccine Supply Chain

Price: Starting at USD 3,000
Publish Date: 28 Mar 2021
Code: PT-2514
Research Type: Presentation
Actionable Benefits

Actionable Benefits

  • Determine best practices for enabling and enhancing the global vaccine supply chain.
  • Assess if your supply chain has fully addressed all the logistical challenges to participate effectively.
  • Comprehend the changes to the COVID-19 vaccine development process for future vaccine development models.
Research Highlights

Research Highlights

  • Five-year cold chain for pharma forecast, with regional insights.
  • Under-called reverse logistics that impact profitability, timelines and regulatory compliance.
  • Mapping of all major global vaccines in production and development, with status.
Critical Questions Answered

Critical Questions Answered

  • Who is working on digital passports and what are the considerations for deployment?
  • What are the current vaccine temperature requirements ETE by manufacturer?
  • What manufacturing technologies are needed to advance and optimize future development and production?